SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Texas Capital Bancshares, Inc. (TCBIO) trades at a trailing P/E of 13.6, forward P/E of 2.9. Trailing earnings yield is 7.33%, forward earnings yield 34.48%. PEG 0.06 (Peter Lynch undervalued ≤1.0). Graham Number is $115.38.
Criteria proven by this page:
- VALUE (77/100, Pass) — P/E is below market average (13.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.06); earnings yield beats bond yields (7.33%).
- Forward P/E 2.9 (down from trailing 13.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.33% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 34.48% as earnings recover.
Overall SharesGrow Score: 69/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
77/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TCBIO
Valuation Multiples
P/E (TTM)13.6
Forward P/E2.9
PEG Ratio0.06
Forward PEG0.25
P/B Ratio1.24
P/S Ratio2.21
EV/EBITDA7.2
Per Share Data
EPS (TTM)$7.34
Forward EPS (Est.)$7.58
Book Value / Share$80.66
Revenue / Share$44.40
FCF / Share$17.67
Yields & Fair Value
Earnings Yield7.33%
Forward Earnings Yield34.48%
Dividend Yield0.00%
Graham Number$115.38
SharesGrow IV$130.66 (+495%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
23.4 |
3.63 |
1.81 |
4.76 |
0.27% |
| 2017 |
22.4 |
1.10 |
2.00 |
4.70 |
0.22% |
| 2018 |
8.7 |
0.16 |
1.02 |
2.08 |
0.38% |
| 2019 |
9.1 |
1.33 |
1.02 |
1.99 |
0.34% |
| 2020 |
45.3 |
-0.55 |
1.05 |
2.55 |
0.32% |
| 2021 |
12.0 |
0.04 |
0.95 |
3.09 |
0.61% |
| 2022 |
9.2 |
0.27 |
1.00 |
2.44 |
0.57% |
| 2023 |
16.4 |
-0.38 |
0.97 |
1.73 |
0.56% |
| 2024 |
47.0 |
-0.73 |
1.08 |
2.07 |
0.47% |
| 2025 |
12.3 |
0.03 |
1.12 |
2.04 |
0.42% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$3.11 |
$762.49M |
$155.12M |
20.3% |
| 2017 |
$3.73 |
$938.05M |
$197.06M |
21% |
| 2018 |
$5.79 |
$1.23B |
$293.39M |
23.9% |
| 2019 |
$6.21 |
$1.44B |
$312.02M |
21.7% |
| 2020 |
$1.12 |
$1.18B |
$66.29M |
5.6% |
| 2021 |
$4.60 |
$987.05M |
$253.94M |
25.7% |
| 2022 |
$6.18 |
$1.25B |
$332.48M |
26.7% |
| 2023 |
$3.54 |
$1.79B |
$189.14M |
10.6% |
| 2024 |
$2.03 |
$1.76B |
$77.51M |
4.4% |
| 2025 |
$6.80 |
$2B |
$330.24M |
16.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.53 |
$7.36 – $7.75 |
$1.35B |
$1.33B – $1.38B |
1 |
| 2027 |
$8.42 |
$8.23 – $8.67 |
$1.45B |
$1.42B – $1.48B |
1 |
| 2028 |
$9.88 |
$9.65 – $10.17 |
$1.57B |
$1.54B – $1.61B |
1 |
